Vernonia amygdalina: Anticancer activity, authentication, and adulteration detection

International Journal of Environmental Research and Public Health

Volumn 5, Issue 5, 2008, Pages 342-348

  Gresham, Lecia J ^a   Ross, Jetaime ^a   Izevbigie, Ernest B ^a  

^a Jackson State University   (United States)

Author keywords

Activity prediction; Anti cancer; Standardization; Vernonia amygdalina

Indexed keywords

ESTROGEN RECEPTOR; GENOMIC DNA; PACLITAXEL; VERNONIA AMYGDALINA EXTRACT;

ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL COUNT; CELL GROWTH; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DNA ISOLATION; DNA SYNTHESIS; DRUG EXPOSURE; DRUG SAFETY; HEALTH DISPARITY; HUMAN; HUMAN CELL; IN VITRO STUDY;

VERNONIA AMYGDALINA;

EID: 58849108514     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph5050342     Document Type: Conference Paper

References (34)

1. American Cancer Society. Cancer Facts & Letters, 2007. Atlanta, GA
2. American Cancer Society. Cancer Statistics, 2008
3. Dougherty, M. K.; Schumaker, L. M.; Jordan, V. C.; Welshons, W. V.; Curran, E. M.; Ellis, M. J.; El-Ashry, D.: Estrogen Receptor Expression and Sensitivity to Paclitaxel in Breast Cancer. Cancer Biology & Therapy, 2004, 3(5), 460-467.
4. Sui, M.; Huang, Y.; Park, B. H.; Davidson, N. E.; Fan, W.: Estrogen Receptor A Mediates Breast Cancer Cell Resistance to Paclitaxel through Inhibition of Apoptotic Cell Death. Cancer Research 2007, 67(11).
5. Cunningham, J. E.; Butler, W. M.: Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Research and Treatment, 2004, 88(2), 161-176
6. Ziv, E.; Tice, J.; Smith-Bindman, R., Shepherd, J.; Cummings, S.; Kerlikowske, K.: Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiology Biomarkers and Prevention, 2004, 13(12), 2090-2905.
7. Woodward, W. A.; Hwang, E. H.; McNeese, M.D.; Perkins, G. H.; Tucker, S. L.; Strom, E.A.; Middleton, L.; Hahn, K.; Hortobagyi, G. N.; Buchholz, T. A.: African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer, 2006, 107(11), 2662-8.
8. Oleszek, W.; Igile. G.; Burda, S.; Jurzysta, M.: Nutritional assessment of Vernonia amygdalina leaves in growing mice. Journal of Agricultural and Food Chemistry, 1995, 4, 2162-2166.
9. Farombi, E. O.: African indigenous plants with chemotherapeutic potentials and biotechnological approach to the production of bioactive prophylactic agents. African Journal of Biotechnology, 2003, 2(12), 662-671.
10. Erasto, P.; Grierson, D. S.; Afolayan, A. J.: Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. J Ethnopharmacology. 2006, 106, 117-120.
11. Moundipa, P. F.; Kamini, G.; Flore, M.; Bilong Bilong, C. F.; Bruchhaus, I.: In vitro amoebicidal activity of some medicinal plants of the Bamun region (Cameroon). African J Trad CAM, 2005, 2(2), 113-121.
12. Akah, P. A.; Ekekwe, R. K.: Ethnopharmacology of some of the asteraceae family used in the Nigerian traditional medicine. Fitoterapia, 1995, 66, 352-355.
13. Akah, P. A.; Okafor, C. L.: Blood sugar lowering effects of V. amygdalina Del in an experimental rabbit model. Phytother Res, 1992, 6, 171-173.
14. Akinpelu D. A.: Antimicrobial activity of Vernonia amygdalina leaves. Fitoterapi, 1999, 70, 432-234.
15. Krief, S.; Hladik, C.; Haxaire, C.: Ethnomedicinal and bioactive properties of plants ingested by wild chimpanzees in Uganda. Journal of Ethnopharmacology, 2005, 101, 1-5.
16. Iwalokun, B. A.; Efedede, B. U.; Alabi-Sofunde, J. A.; Oduala, T.; Magbagbeola, O. A.; Akinwande, A. I.: Hepatoprotective and antioxidant activities of Vernonia amygdalina on acetaminophen-induced hepatic damage on mice. Journal of Medicinal Food, 2006, 9(4), 524-30.
17. Kupchan, S. M.; Hemingway, R. J.; Karim, A.; Werner, D.: Tumor inhibitors. XLVII. Vernodalin and Vernomygdin, two new cytotoxic sesquiterpene lactones from Vernonia amygdalina Del. Journal of Organic chemistry, 1969, 34, 3908-3911.
18. Jasaka, M.; Ohigashi, H.; Takagaki, T.; Nozaki, H.; Tada, T.; Hiroto, M.; Irie, R.; Huffman, M. A.; Nishida, T.; Kaji, M.; Koshimizu, K.: Bitter steroid glucosides, Vernoniosides A1, A2,A3 and related B1 from possible medicinal plant-Vernonia amygdalina used by wild chimpanzees. Tetrahedron, 1992, 48(4), 625-632.
19. Izevbigie, E. B.: Discovery of water soluble anticancer agents (Edotides) from vegetables found in Benin City, Nigeria. Exp.Biol.Med., 2003, 228, 293-298
20. Howard, C. B.; Stevens, J.; Izevbigie, E. B.; Walker, A.; McDaniel, O.: Time and dose-dependent modulation of phase 1 and phase 2 gene expression in response to treatment of MCF-7 cells with a natural anti-cancer agent. Cell. Mol. Biol., 2003, 49(7), 1057-1065.
21. Izevbigie, E. B.; Bryant, J. L.; Walker, A.: A novel natural inhibitor of extracellular signal-regulated kinases and human breast cancer cell growth. Exp.Bio.Med., 2004, 229, 163-169.
22. Opata, M.; Izevbigie, E. B.: Aqueous V. amygdalina Extracts Alter MCF-7 Cell Membrane Permeability and Efflux. Int. J. Environ. Res. Public Health, 2006, 3(2), 174-179.
23. Sayed, M. D.; Zaki, A. Y.; El-Marzabai, M. M.; Doss, S. L.: Medicinal Plants. Phytochemistry: 1987, 21, 944.
24. Tona, L.; Cimanga, R. K.; Mesia, K.; Musuamba, C. T.; De Bruyne, T.; Apers, S.; Hermans, N.; Van Miret, S.; Pieters, L.; Totté, J.; Vlietink, A. J.: In Vitro Antiplasmodial activity of extracts and fractions of seven medicinal plants used in the Democratic Republic of Congo. Journal of Ethnophamacology, 2004, 93(1), 27-32.
25. Harborne, J. B.: Phytochemical Methods. London, Chapman and Hall: New York, USA, 1973; pp 278.
26. Wall, M. E.; Wani, M. C.; Manikumar, G.; Abraham, P.; Taylor, H.; Huges, T. J.; Warner, J.; MacGivney, R.: Plant antimutagenic agents, flavonoids. Journal of Natural Products, 1998, 51(6), 1084 -109.
27. GraphPad Software. GraphPad Software, Inc. Sand Diego, CA, USA.
28. Aparajita, G.; Akech, J.; Mukherjee, S.; Das S. K.: Differential expression of cholinephosphotransferase in normal and cancerous human mammary epithelial cells. Biochem. Biophys. Res. 2002, Comm. 297, 1043-1048.
29. Fonagy, A.; Swiderski, C.; Ostrovsky, A. M.; Bolton, W.E.; Freeman, J.E.: Effect of nuclear P120 expression level on the proliferation capacity of breast cancer cells. Cancer Research, 1994, 54, 1859-1864.
30. Greenwald, P.; Clifford, C. K.; Milner, J. A.: Diet and cancer prevention. European Journal of Cancer, 2001, 37(8), 948-965.
31. Hennekens, C.; Buring, J. E.; Mayrent, S. L.: Epidemiology in Medicine. Lippincott Williams and Wilkins: 1987, 3, pp 36.
32. Peto, R.; Doll, R.; Buckley, J. D.; Sporn, M. B.: Can dietary beta-carotene materially reduce human cancer rates? Nature, 1981, 290, 201-208.
33. Cragg, G. M.; Newman, D. J.: International collaboration in drug discovery and development from natural sources. Pure Appl. Chem., 2005, 77(11), 1923-1942.
34. Vladusic, E. A.; Hornby, A. E.; Guerra-Vladusic, F. K.; Lakins, J.; Lupu, R.: Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. Oncol. Rep., 2000, 7(1), 157-167